Ditchcarbon
  • Customers
  1. Organizations
  2. EMS
Public Profile
Pharmaceutical Preparation Manufacturing
BR
updated a month ago

EMS

Company website

EMS, officially known as EMS S/A, is a leading Brazilian pharmaceutical company headquartered in Jaguariúna, São Paulo. Founded in 1964, EMS has established itself as a key player in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of generic and branded medications. With a strong presence across Brazil and significant operations in Latin America, EMS has achieved notable milestones, including becoming one of the largest pharmaceutical companies in Brazil. The company is renowned for its extensive portfolio of high-quality products, which includes prescription medications, over-the-counter drugs, and a variety of therapeutic classes. EMS distinguishes itself through its commitment to innovation and quality, ensuring that its offerings meet the highest industry standards. With a robust market position, EMS continues to contribute significantly to the healthcare sector, making it a trusted name among healthcare professionals and patients alike.

DitchCarbon Score

How does EMS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

32

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

EMS's score of 32 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.

58%

Let us know if this data was useful to you

EMS's reported carbon emissions

In 2022, EMS, headquartered in Brazil, reported total carbon emissions of approximately 22,000,000 kg CO2e. This figure includes 18,242,150 kg CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources. Additionally, Scope 2 emissions, related to the generation of purchased electricity, amounted to about 3,668,750 kg CO2e. The company also reported Scope 3 emissions, which cover indirect emissions from the value chain, totalling approximately 3,771,590 kg CO2e. Despite the significant emissions figures, EMS has not publicly disclosed specific reduction targets or initiatives as part of its climate commitments. The emissions data is cascaded from its parent company, EMS S.A., indicating a corporate family relationship that influences its reporting and sustainability strategies. As a current subsidiary, EMS is part of a broader commitment to addressing climate change, although specific initiatives or pledges have not been detailed in the available data. The company continues to align with industry standards for emissions reporting and climate action, reflecting a growing awareness of environmental responsibilities within the sector.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2022
Scope 1
18,242,150
Scope 2
3,668,750
Scope 3
3,771,590

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. EMS's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for EMS is in BR, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

EMS is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Pint Pharma GmbH

AT
•
Pharmaceutical Preparation Manufacturing
Updated 19 days ago

Johnson Controls

US
•
Construction work (45)
Updated 2 days ago

Genentech USA, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Roemmers

AR
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Emerson Electric

US
•
Electrical machinery and apparatus n.e.c. (31)
Updated 1 day ago

Glaxosmithkline

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 7 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
dev
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy